• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

地屈孕酮的体外、体内和对人子宫内膜的孕激素作用。

Progestational effects of dydrogesterone in vitro, in vivo and on the human endometrium.

机构信息

Institute for Medical Research and Education, Essen, Germany.

出版信息

Maturitas. 2009 Dec;65 Suppl 1:S3-11. doi: 10.1016/j.maturitas.2009.10.011. Epub 2009 Dec 6.

DOI:10.1016/j.maturitas.2009.10.011
PMID:19969432
Abstract

Dydrogesterone has a molecular structure closely related to that of natural progesterone, but it has enhanced oral availability compared with progesterone. The hormonal profile and the progestational potency of dydrogesterone has been determined in vitro, in vivo and in humans, in combination with estrogens or without. It showed varying affinity for progesterone-binding proteins in uterine tissue in vitro, depending on the species. It exerted a clear progestational response in the rabbit in vivo, although the potency was influenced somewhat by the route of administration. When used in hormone replacement therapy, 10mg dydrogesterone given sequentially provides adequate protection against endometrial hyperplasia in postmenopausal women using 2mg estradiol. Similarly, a dydrogesterone dose of 5mg also protects the endometrium when continuously combined with 1mg estradiol. Dydrogesterone also has beneficial effects in women with amenorrhea/oligomenorrhea, dysfunctional uterine bleeding and irregular cycles. In conclusion, having a similar profile to progesterone but with better oral availability, dydrogesterone has been used successfully to treat disorders related to absolute or relative progesterone deficiency.

摘要

地屈孕酮的分子结构与天然孕酮非常相似,但与孕酮相比,其口服生物利用度更高。地屈孕酮的激素谱和孕激素效价已在体外、体内和人体中得到确定,可与雌激素联合使用或不联合使用。它在体外对子宫组织中的孕激素结合蛋白表现出不同的亲和力,具体取决于物种。它在体内对兔有明显的孕激素反应,尽管效力在一定程度上受到给药途径的影响。在激素替代治疗中,10mg 地屈孕酮序贯给药,与 2mg 雌二醇联合使用可充分预防绝经后妇女的子宫内膜增生。同样,当与 1mg 雌二醇连续联合使用时,5mg 的地屈孕酮剂量也可保护子宫内膜。地屈孕酮对闭经/稀发排卵、功能失调性子宫出血和不规则周期的妇女也有有益的作用。总之,地屈孕酮具有与孕酮相似的作用模式,但口服生物利用度更好,已成功用于治疗与绝对或相对孕激素缺乏相关的疾病。

相似文献

1
Progestational effects of dydrogesterone in vitro, in vivo and on the human endometrium.地屈孕酮的体外、体内和对人子宫内膜的孕激素作用。
Maturitas. 2009 Dec;65 Suppl 1:S3-11. doi: 10.1016/j.maturitas.2009.10.011. Epub 2009 Dec 6.
2
Ultra low dose continuous combined hormone replacement therapy with 0.5mg 17beta-oestradiol and 2.5mg dydrogesterone: protection of the endometrium and amenorrhoea rate.超低剂量连续联合激素替代治疗,使用 0.5 毫克 17β-雌二醇和 2.5 毫克地屈孕酮:保护子宫内膜和闭经率。
Maturitas. 2010 Jun;66(2):201-5. doi: 10.1016/j.maturitas.2010.03.007. Epub 2010 Apr 7.
3
Use of dydrogesterone in hormone replacement therapy.地屈孕酮在激素替代疗法中的应用。
Maturitas. 2009 Dec;65 Suppl 1:S51-60. doi: 10.1016/j.maturitas.2009.09.013.
4
Endometrial safety and bleeding patterns during a 2-year study of 1 or 2 mg 17 beta-estradiol combined with sequential 5-20 mg dydrogesterone.在一项为期两年的研究中,1毫克或2毫克17β-雌二醇联合序贯使用5 - 20毫克地屈孕酮时的子宫内膜安全性和出血模式。
Climacteric. 2002 Mar;5(1):26-35.
5
Cardiovascular risk markers during treatment with estradiol and trimegestone or dydrogesterone.使用雌二醇与屈美孕酮或地屈孕酮治疗期间的心血管风险标志物
Maturitas. 2009 Mar 20;62(3):287-93. doi: 10.1016/j.maturitas.2009.01.004. Epub 2009 Mar 5.
6
Endometrial morphology during hormone replacement therapy with estradiol gel combined to levonorgestrel-releasing intrauterine device or natural progesterone.使用雌二醇凝胶联合左炔诺孕酮宫内节育器或天然孕酮进行激素替代治疗期间的子宫内膜形态
Acta Obstet Gynecol Scand. 1998 Aug;77(7):758-63.
7
Transdermal sequential and continuous hormone replacement regimens with estradiol and norethisterone acetate in postmenopausal women: effects on the endometrium.绝经后妇女使用雌二醇和醋酸炔诺酮的经皮序贯和连续激素替代方案:对子宫内膜的影响。
Int J Fertil Womens Med. 1997;42 Suppl 2:388-98.
8
Prevention of postmenopausal bone loss using tibolone or conventional peroral or transdermal hormone replacement therapy with 17beta-estradiol and dydrogesterone.使用替勃龙或含17β-雌二醇和地屈孕酮的传统口服或经皮激素替代疗法预防绝经后骨质流失。
J Bone Miner Res. 1997 May;12(5):806-12. doi: 10.1359/jbmr.1997.12.5.806.
9
Indications for therapy with progestational agents.
Bull Schweiz Akad Med Wiss. 1970 Oct;25(4-6):541-4.
10
Continuous combined hormone replacement therapy with 1 mg 17beta-oestradiol and 5 mg dydrogesterone (Femoston-conti): endometrial safety and bleeding profile.含1毫克17β-雌二醇和5毫克地屈孕酮的连续联合激素替代疗法(芬吗通持续疗法):子宫内膜安全性和出血情况
Maturitas. 2006 Feb 20;53(3):299-305. doi: 10.1016/j.maturitas.2005.05.015. Epub 2005 Jul 25.

引用本文的文献

1
Kir7.1 is the physiological target for hormones and steroids that regulate uteroplacental function.Kir7.1是调节子宫胎盘功能的激素和类固醇的生理靶点。
Sci Adv. 2025 Mar 7;11(10):eadr5086. doi: 10.1126/sciadv.adr5086. Epub 2025 Mar 5.
2
Birth defects reporting and the use of dydrogesterone: a disproportionality analysis from the World Health Organization pharmacovigilance database (VigiBase).出生缺陷报告与炔诺孕酮的使用:来自世界卫生组织药物警戒数据库(VigiBase)的不成比例性分析
Hum Reprod Open. 2025 Jan 2;2025(1):hoae072. doi: 10.1093/hropen/hoae072. eCollection 2025.
3
Real-World Evidence of Dydrogesterone 20 mg and 30 mg SR Usage in Pregnancy.
20毫克和30毫克缓释炔诺酮在孕期使用的真实世界证据。
Cureus. 2024 Oct 21;16(10):e72016. doi: 10.7759/cureus.72016. eCollection 2024 Oct.
4
No additional risk of congenital anomalies after first-trimester dydrogesterone use: a systematic review and meta-analysis.孕早期使用醋酸甲羟孕酮后先天性异常无额外风险:一项系统评价和荟萃分析。
Hum Reprod Open. 2024 Jan 23;2024(1):hoae004. doi: 10.1093/hropen/hoae004. eCollection 2024.
5
The Role of Dydrogesterone in the Management of Luteal Phase Defect: A Comprehensive Review.地屈孕酮在黄体期缺陷管理中的作用:一项综述
Cureus. 2023 Nov 3;15(11):e48194. doi: 10.7759/cureus.48194. eCollection 2023 Nov.
6
The Effect of Progestins on Cytokine Production in the Peripheral Blood Mononuclear Cells of Menopausal Women and Their Luminol-Dependent Chemiluminescence.孕激素对绝经后妇女外周血单个核细胞细胞因子产生的影响及其与鲁米诺依赖性化学发光的关系。
Molecules. 2023 May 26;28(11):4354. doi: 10.3390/molecules28114354.
7
Association between serum progesterone levels on the day of frozen-thawed embryo transfer and pregnancy outcomes after artificial endometrial preparation.冻融胚胎移植日血清孕酮水平与人工子宫内膜准备后妊娠结局的关系。
BMC Pregnancy Childbirth. 2023 May 30;23(1):401. doi: 10.1186/s12884-023-05596-4.
8
Individualized conservative therapeutic strategies for adenomyosis with the aim of preserving fertility.以保留生育能力为目的的子宫腺肌病个体化保守治疗策略。
Front Med (Lausanne). 2023 Mar 30;10:1133042. doi: 10.3389/fmed.2023.1133042. eCollection 2023.
9
Prevention of Pregnancy Loss: Combining Progestogen Treatment and Psychological Support.预防流产:孕激素治疗与心理支持相结合。
J Clin Med. 2023 Feb 24;12(5):1827. doi: 10.3390/jcm12051827.
10
Additional dydrogesterone for the treatment of chronic endometritis treated with antibiotic in premenopausal women with endometrial polyps: a retrospective cohort study.在绝经前子宫内膜息肉患者中,抗生素治疗慢性子宫内膜炎时加用地屈孕酮治疗:一项回顾性队列研究。
BMC Womens Health. 2022 Nov 5;22(1):435. doi: 10.1186/s12905-022-02033-0.